A concerning phenomenon is surfacing within the drug scene: "Pink copyright," formally known as Flunitramadol. This manufactured opioid is being distributed as a crystal , often packaged as copyright, posing a grave danger to individuals . Its deceptively low price and easy accessibility are leading